Daratumumab Plus Ibrutinib in Patients With Waldenstrӧm's Macroglobulinemia
about
Daratumumab Plus Ibrutinib in Patients With Waldenstrӧm's Macroglobulinemia
description
clinical trial
@en
klinisch onderzoek
@nl
name
Daratumumab Plus Ibrutinib in Patients With Waldenstrӧm's Macroglobulinemia
@en
type
label
Daratumumab Plus Ibrutinib in Patients With Waldenstrӧm's Macroglobulinemia
@en
prefLabel
Daratumumab Plus Ibrutinib in Patients With Waldenstrӧm's Macroglobulinemia
@en
P1476
A Phase II Study of Daratumuma ...... aldenstrӧm's Macroglobulinemia
@en
P3098
NCT03679624
P4844
P580
2019-03-01T00:00:00Z
P582
2022-03-01T00:00:00Z